Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies (Q34276476)
Jump to navigation
Jump to search
scientific article published on November 13, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies |
scientific article published on November 13, 2003 |
Statements
1 reference
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies (English)
1 reference
Kiran Khandke
1 reference
Latha Sridharan
1 reference
Arthur Kunz
1 reference
Boris Gorovits
1 reference
Chandrasekhar Udata
1 reference
Sue Stephens
1 reference
Philip Frost
1 reference
John F. DiJoseph
Douglas C. Armellino
Erwin R. Boghaert
Maureen M. Dougher
Philip R. Hamann
Justin K. Moran
Andrew G. Popplewell
13 November 2003
1 reference
Identifiers
1 reference